EN PL
PRACA ORYGINALNA
The usefulness of histopathological examinations of non-renal biopsies in the diagnosis of granulomatosis with polyangiitis
 
Więcej
Ukryj
 
Data nadesłania: 07-09-2017
 
 
Data ostatniej rewizji: 25-10-2017
 
 
Data akceptacji: 27-10-2017
 
 
Data publikacji online: 28-10-2017
 
 
Data publikacji: 31-10-2017
 
 
Reumatologia 2017;55(5):230-236
 
SŁOWA KLUCZOWE
DZIEDZINY
STRESZCZENIE
Introduction: Granulomatosis with polyangiitis (GPA) is a rare, ANCA-associated, systemic disease characterized by necrotizing small and medium vessel vasculitis of unknown etiology associated with granulomatous inflammation affecting the renal, pulmonary, upper airways, ocular systems and other tissues. Histological proof of the granulomatosis with polyangiitis (GPA) can be obtained by biopsy of clinically involved sites. The main purpose of this study was to examine histopathological changes in non-renal biopsies from patients with established diagnosis of GPA and evaluated the histological confirmation at diagnosis of this disease.
Material and methods: A retrospective analysis was performed in patients with GPA diagnosed and treated in clinics of the University Clinical Center (UCK) in Gdansk in 1988–2009.
Results: In the analyzed group of GPA patients the histopathological examination of biopsies taken from involved tissues (except kidney) was performed in 60% of patients. Thirty-six out of 93 biopsies (39%) were diagnosed as typical of GPA, 10 (10.7%) were suggestive and 51 (54.8%) were non-specific. Considering all biopsies, the diagnosis was confirmed in 24 patients (57% of patients in whom biopsies were taken). Epitheloid cell granulomas were present in 33 biopsies (43%), characteristic necrosis in 27 biopsies (35%), small vessel vasculitis in 18 biopsies (23%), while multinucleated giant cells were identified only in 9 biopsies (12%).
Conclusions: Histopathological examination of the affected tissues remains the gold standard of the diagnosis of GPA. Its usefulness increases, particularly in ANCA-negative patients, in the initial phase of the disease, or in patients with atypical clinical presentation. In many cases, it is necessary to repeat biopsy to establish the diagnosis. The role of the histopathological examination seems to be particularly important when ANCA is negative or clinical symptoms are atypical of GPA.
 
REFERENCJE (24)
1.
Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 1990; 33: 1101-1107.
 
2.
Jennette JC, Falk RJ, Bacon PA, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65: 1-11.
 
3.
Yates M, Watts RA, Bajema IM, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 2016; 75: 1583-1594.
 
4.
Maguchi S, Fukuda S, Takizawa M. Histological findings in biopsies from patients with cytoplasmic-antineutrophil cytoplasmic antibody (cANCA)-positive Wegener’s granulomatosis. Auris Nasus Larynx 2001; 28: S53-S58.
 
5.
Devaney KO, Travis WD, Hoffman G, et al. Interpretation of head and neck biopsies in Wegener’s granulomatosis: a pathologic study of 136 biopsies from 70 patients. Am J Surg Pathol 1990; 14: 555-564.
 
6.
Aasarød K, Iversen BM, Hammerstrøm J, et al. Wegener’s granulomatosis: clinical course in 108 patients with renal involvement. NDT 2000; 15: 611-618.
 
7.
Mukhtyar C, Guillevin L, Cid MC, et al. EULAR Recommendations for management of primary small and medium vessel vasculitis 2009. Ann Rheum Dis 2009; 68: 310-317.
 
8.
Watts RA, Lane SE, Bentham G, et al. Epidemiology of systemic vasculitis. A ten-year study in the United Kingdom. Arthritis Rheum 2000; 43: 414-419.
 
9.
Koldingsnes W, Nossent H. Epidemiology of Wegener’s granulomatosis in Northern Norway. Arthritis Rheum 2000; 43: 2481-2487.
 
10.
Mohammad AJ, Jacobsson LT, Mahr AD, et al. Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology 2007; 46: 1329-1337.
 
11.
Van der Woude FJ, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener’s granulomatosis. Lancet 1985; 1: 425-429.
 
12.
Wiatr E, Gawryluk D. New aspects of the pathogenesis of Wegener’s granulomatosis. Pneumon Alergol Pol 2002; 70: 326-333.
 
13.
Jennette JC. Nomenclature and classification of vasculitis: lessons learned from granulomatosis with polyangiitis (Wegener’s granulomatosis). Clin Exp Immunol 2011; 164 (Suppl 1): 7-10.
 
14.
Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener’s granulomatosis: an analysis of 159 patients. Ann Intern Med 1992; 116: 488-498.
 
15.
Jennings CR, Jones NS, Dugar J, et al. Wegener’s granulomatosis – a review of diagnosis and treatment in 53 subjects. Rhinology 1998; 36: 188-191.
 
16.
Anderson G, Coles ET, Crane M, et al. Wegener’s granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J M 1992; 83: 427-438.
 
17.
Stone JH. The Wegener’s Granulomatosis Etanercept Trial Research Group: Limited versus severe Wegener’s granulomatosis. Baseline data on patients in the Wegener’s granulomatosis Etanercept Trial. Arthritis Rheum 2003; 48: 2299-2309.
 
18.
Lie JT. Biopsy diagnosis of systemic vasculitis. Baillieres Clin Rheumatol 1997; 11: 219-236.
 
19.
Langford C. How can relapses be detected and prevented in primary systemic small-vessel vasculitides? Clin Rheumatol 2005; 19: 307-320.
 
20.
Schnabel A, Holl-Ulrich K, Dalhoff K, et al. Efficacy of transbronchial biopsy in pulmonary vasculitides. Eur Respir J 1997; 10: 2738-2743.
 
21.
Takwoingi YM, Dempster JH. Wegener’s granulomatosis: an analysis of 33 patients seen over a 10-year period. Clin Otolaryngol 2003; 28: 187-194.
 
22.
Bajema IM, Hagen EC, Weverling-Rijnsburger AW, et al. Wegener’s granulomatosis: a meta-analysis of 349 literary case reports. J Lab Clin Med 1997; 129: 17-22.
 
23.
Lamprecht P, Trabandt A, Gross W. Clinical and immunological aspects of Wegener’s granulomatosis (WG) and other syndromes resembling WG. IMAJ 2000; 2: 621-626.
 
24.
Chang SY, Keogh KA, Lewis JE, et al. IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener’s): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases. Human Pathol 2013; 44: 2432-2437.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top